{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:03:47Z","timestamp":1794002627149,"version":"4.8.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.transci.2023.103844","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T15:42:16Z","timestamp":1699026136000},"page":"103844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic apheresis in renal transplantation: An update"],"prefix":"10.1016","volume":"63","author":[{"given":"Christina","family":"Melexopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilis","family":"Filiopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smaragdi","family":"Marinaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.transci.2023.103844_bib1","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s40620-022-01453-3","article-title":"History of kidney transplantation: a journey of progression and evolution for success","volume":"35","author":"Tantisattamo","year":"2022","journal-title":"J Nephrol"},{"issue":"3","key":"10.1016\/j.transci.2023.103844_bib2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.transci.2019.04.010","article-title":"Therapeutic plasma exchange in nephrology. Where it applies?","volume":"58","author":"Alamartine","year":"2019","journal-title":"Transfus Apher Sci"},{"issue":"12 Suppl","key":"10.1016\/j.transci.2023.103844_bib3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1097\/01.tp.0000296102.94695.c0","article-title":"Present techniques for antibody removal","volume":"84","author":"Tyden","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2023.103844_bib4","first-page":"406","article-title":"Double filtration plasmapheresis","volume":"26","author":"Agishi","year":"1980","journal-title":"Trans Am Soc Artif Intern Organs"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib5","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/jca.21265","article-title":"The selective therapeutic apheresis procedures","volume":"28","author":"Sanchez","year":"2013","journal-title":"J Clin Apher"},{"issue":"6","key":"10.1016\/j.transci.2023.103844_bib6","first-page":"4538","article-title":"Present experiences in a series of 26 ABO-incompatible living donor renal allografts","volume":"19","author":"Alexandre","year":"1987","journal-title":"Transpl Proc"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib7","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1600-6143.2004.00653.x","article-title":"ABO incompatible kidney transplantations without splenectomy, using antigen-specific immunoadsorption and rituximab","volume":"5","author":"Tyden","year":"2005","journal-title":"Am J Transpl"},{"issue":"2","key":"10.1016\/j.transci.2023.103844_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103673","article-title":"Plasmapheresis in ABO incompatible kidney transplant","volume":"62","author":"Vrielink","year":"2023","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2023.103844_bib9","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.2147\/JIR.S360460","article-title":"Current perspectives in ABO-incompatible kidney transplant","volume":"15","author":"Maritati","year":"2022","journal-title":"J Inflamm Res"},{"issue":"2","key":"10.1016\/j.transci.2023.103844_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jca.22043","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice - evidence-based approach from the writing committee of the american society for apheresis: the ninth special issue","volume":"38","author":"Connelly-Smith","year":"2023","journal-title":"J Clin Apher"},{"issue":"2","key":"10.1016\/j.transci.2023.103844_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1537-2995.2011.03465.x","article-title":"Recommendations for transfusion in ABO-incompatible hematopoietic stem cell transplantation","volume":"52","author":"O'Donghaile","year":"2012","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.transci.2023.103844_bib12","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/ndt\/gfr237","article-title":"The efficacy of antigen-specific immunoadsorption and rebound of anti-A\/B antibodies in ABO-incompatible kidney transplantation","volume":"26","author":"Genberg","year":"2011","journal-title":"Nephrol Dial Transpl"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib13","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/tri.12412","article-title":"ABO-incompatible kidney transplant recipients have a higher bleeding risk after antigen-specific immunoadsorption","volume":"28","author":"de Weerd","year":"2015","journal-title":"Transpl Int"},{"issue":"8","key":"10.1016\/j.transci.2023.103844_bib14","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1093\/ndt\/gfq264","article-title":"Immunoadsorption in nephrology and kidney transplantation","volume":"25","author":"Schwenger","year":"2010","journal-title":"Nephrol Dial Transpl"},{"issue":"5","key":"10.1016\/j.transci.2023.103844_bib15","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1093\/ndt\/gfr610","article-title":"Anti-A\/B antibody depletion by semiselective versus ABO blood group-specific immunoadsorption","volume":"27","author":"Wahrmann","year":"2012","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.transci.2023.103844_bib16","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fimmu.2017.00234","article-title":"ABO-incompatible kidney transplantation","volume":"8","author":"Morath","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.transci.2023.103844_bib17","first-page":"307","article-title":"ABO-incompatible kidney transplantation: long-term outcomes","author":"Tanabe","year":"2013","journal-title":"Clin Transpl"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trre.2012.07.003","article-title":"ABO-incompatible kidney transplantation","volume":"27","author":"Takahashi","year":"2013","journal-title":"Transpl Rev"},{"issue":"4","key":"10.1016\/j.transci.2023.103844_bib19","doi-asserted-by":"crossref","first-page":"329","DOI":"10.5500\/wjt.v5.i4.329","article-title":"Excellent long term patient and renal allograft survival after ABO-incompatible kidney transplantation: experience of one center","volume":"5","author":"Melexopoulou","year":"2015","journal-title":"World J Transpl"},{"issue":"9","key":"10.1016\/j.transci.2023.103844_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1097\/01.tp.0000262570.18117.55","article-title":"Implementation of a protocol for ABO-incompatible kidney transplantation--a three-center experience with 60 consecutive transplantations","volume":"83","author":"Tyden","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2023.103844_bib21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3390\/jcm10061316","article-title":"Apheresis efficacy and tolerance in the setting of hla-incompatible kidney transplantation","volume":"10","author":"Noble","year":"2021","journal-title":"J Clin Med"},{"issue":"6","key":"10.1016\/j.transci.2023.103844_bib22","doi-asserted-by":"crossref","first-page":"103","DOI":"10.5500\/wjt.v9.i6.103","article-title":"Therapeutic apheresis in kidney transplantation: an updated review","volume":"9","author":"Salvadori","year":"2019","journal-title":"World J Transpl"},{"issue":"3","key":"10.1016\/j.transci.2023.103844_bib23","first-page":"288","article-title":"Kidney transplants from HLA-incompatible live donors and survival","volume":"375","author":"Orandi","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2023.103844_bib24","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/TP.0000000000000064","article-title":"Benefits of rituximab combined with intravenous immunoglobulin for desensitization in kidney transplant recipients","volume":"98","author":"Vo","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2023.103844_bib25","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/TP.0b013e3181da1cc3","article-title":"Combined posttransplant prophylactic IVIg\/anti-CD20\/plasmapheresis in kidney recipients with preformed donor-specific antibodies: a pilot study","volume":"89","author":"Loupy","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2023.103844_bib26","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1097\/TP.0000000000001650","article-title":"Long-term outcomes of kidney transplantation in patients with high levels of preformed DSA: the necker high-risk transplant program","volume":"101","author":"Amrouche","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2023.103844_bib27","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1093\/ndt\/17.8.1503","article-title":"Peri-operative immunoadsorption in sensitized renal transplant recipients","volume":"17","author":"Haas","year":"2002","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.transci.2023.103844_bib28","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.TP.0000148732.26761.FA","article-title":"Peritransplant immunoadsorption: a strategy enabling transplantation in highly sensitized crossmatch positive cadaveric kidney allograft recipients","volume":"79","author":"Lorenz","year":"2005","journal-title":"Transplantation"},{"key":"10.1016\/j.transci.2023.103844_bib29","doi-asserted-by":"crossref","unstructured":"Kaplan A.A. Therapeutic plasma exchange: a technical and operational review. J Clin Apher;28(1):3\u201310.","DOI":"10.1002\/jca.21257"},{"issue":"8628","key":"10.1016\/j.transci.2023.103844_bib30","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(89)91672-3","article-title":"Removal of anti-HLA antibodies by extracorporeal immunoadsorption to enable renal transplantation","volume":"1","author":"Palmer","year":"1989","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.transci.2023.103844_bib31","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1432-2277.2012.01447.x","article-title":"Living donor kidney transplantation in crossmatch-positive patients enabled by peritransplant immunoadsorption and anti-CD20 therapy","volume":"25","author":"Morath","year":"2012","journal-title":"Transpl Int"},{"issue":"4","key":"10.1016\/j.transci.2023.103844_bib32","first-page":"367","article-title":"Desensitization in the setting of HLA-incompatible kidney transplant","volume":"16","author":"Malvezzi","year":"2018","journal-title":"Exp Clin Transpl"},{"issue":"2","key":"10.1016\/j.transci.2023.103844_bib33","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMoa013036","article-title":"Risk of renal allograft loss from recurrent glomerulonephritis","volume":"347","author":"Briganti","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.transci.2023.103844_bib34","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1111\/ajt.15898","article-title":"The banff 2019 kidney meeting report (i): updates on and clarification of criteria for t cell- and antibody-mediated rejection","volume":"20","author":"Loupy","year":"2020","journal-title":"Am J Transpl"},{"issue":"7","key":"10.1016\/j.transci.2023.103844_bib35","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1111\/tri.13613","article-title":"An extension of the RITUX-ERAH study, multicenter randomized clinical trial comparing rituximab to placebo in acute antibody-mediated rejection after renal transplantation","volume":"33","author":"Bailly","year":"2020","journal-title":"Transpl Int"},{"issue":"12","key":"10.1016\/j.transci.2023.103844_bib36","doi-asserted-by":"crossref","DOI":"10.1097\/TXD.0000000000000746","article-title":"Rituximab and monitoring strategies for late antibody-mediated rejection after kidney transplantation","volume":"3","author":"Parajuli","year":"2017","journal-title":"Transpl Direct"},{"issue":"11","key":"10.1016\/j.transci.2023.103844_bib37","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1681\/ASN.V12112482","article-title":"C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption","volume":"12","author":"Bohmig","year":"2001","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1600-6143.2006.01613.x","article-title":"Immunoadsorption in severe C4d-positive acute kidney allograft rejection: a randomized controlled trial","volume":"7","author":"Bohmig","year":"2007","journal-title":"Am J Transpl"},{"issue":"10","key":"10.1016\/j.transci.2023.103844_bib39","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.jfma.2016.07.007","article-title":"Repeated cycles of high-dose intravenous immunoglobulin and plasmapheresis for treatment of late antibody-mediated rejection of renal transplants","volume":"115","author":"Lee","year":"2016","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/j.transci.2023.103844_bib40","article-title":"Tocilizumab in the treatment of chronic antibody-mediated rejection post kidney transplantation: clinical and histological monitoring","volume":"8","author":"Noble","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.transci.2023.103844_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2215\/CJN.08970719","article-title":"Recurrence of FSGS after kidney transplantation in adults","volume":"15","author":"Uffing","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"issue":"Suppl 23","key":"10.1016\/j.transci.2023.103844_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1399-0012.2011.01452.x","article-title":"Focal segmental glomerulosclerosis after renal transplantation","volume":"25","author":"Shimizu","year":"2011","journal-title":"Clin Transpl"},{"key":"10.1016\/j.transci.2023.103844_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3390\/jcm10030373","article-title":"Therapeutic options for recurrence of primary focal segmental glomerulonephritis (FSGS) in the renal allograft: single-center experience","volume":"10","author":"Vallianou","year":"2021","journal-title":"J Clin Med"},{"issue":"5","key":"10.1016\/j.transci.2023.103844_bib44","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3109\/0886022X.2015.1015366","article-title":"Individualized scheme of immunoadsorption for the recurrence of idiopathic focal segmental glomerulosclerosis in the graft: a single center experience","volume":"37","author":"Lionaki","year":"2015","journal-title":"Ren Fail"},{"issue":"6","key":"10.1016\/j.transci.2023.103844_bib45","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1093\/ndt\/gfx214","article-title":"Treatment by immunoadsorption for recurrent focal segmental glomerulosclerosis after paediatric kidney transplantation: a multicentre French cohort","volume":"33","author":"Allard","year":"2018","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.transci.2023.103844_bib46","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3389\/fped.2019.00454","article-title":"Dextran-sulfate plasma adsorption lipoprotein apheresis in drug resistant primary focal segmental glomerulosclerosis patients: results from a prospective, multicenter, single-arm intervention study","volume":"7","author":"Raina","year":"2019","journal-title":"Front Pedia"},{"issue":"11","key":"10.1016\/j.transci.2023.103844_bib47","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1007\/s00467-019-04296-6","article-title":"LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients","volume":"34","author":"Shah","year":"2019","journal-title":"Pedia Nephrol"},{"issue":"2","key":"10.1016\/j.transci.2023.103844_bib48","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.kint.2018.11.008","article-title":"Management and treatment of glomerular diseases (part 2): conclusions from a kidney disease: improving global outcomes (KDIGO) controversies conference","volume":"95","author":"Rovin","year":"2019","journal-title":"Kidney Int"},{"issue":"5","key":"10.1016\/j.transci.2023.103844_bib49","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/bcp.12098","article-title":"Population pharmacokinetics of rituximab with or without plasmapheresis in kidney patients with antibody-mediated disease","volume":"76","author":"Puisset","year":"2013","journal-title":"Br J Clin Pharm"},{"issue":"3","key":"10.1016\/j.transci.2023.103844_bib50","doi-asserted-by":"crossref","DOI":"10.1097\/TP.0000000000002008","article-title":"Rituximab and therapeutic plasma exchange in recurrent focal segmental glomerulosclerosis post kidney transplantation","volume":"102","author":"Alasfar","year":"2018","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.transci.2023.103844_bib51","first-page":"1786","article-title":"M SG. Tacrolimus associated localized thrombotic microangiopathy developing in early stage after renal transplantation","volume":"6","author":"Devadoss","year":"2012","journal-title":"J Clin Diagn Res"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib52","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.transci.2018.02.013","article-title":"What is the evidence for the role of therapeutic apheresis in the management of complement-associated thrombotic microangiopathies?","volume":"57","author":"Yildiz","year":"2018","journal-title":"Transfus Apher Sci"},{"issue":"23","key":"10.1016\/j.transci.2023.103844_bib53","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","article-title":"Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome","volume":"368","author":"Legendre","year":"2013","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.transci.2023.103844_bib54","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1038\/sj.ki.5002244","article-title":"Recurrence of ANCA-associated vasculitis following renal transplantation in the modern era of immunosupression","volume":"71","author":"Gera","year":"2007","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.transci.2023.103844_bib55","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/00007890-199704270-00001","article-title":"Recurrent glomerulonephritis following renal transplantation","volume":"63","author":"Kotanko","year":"1997","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib56","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.transproceed.2012.12.021","article-title":"Glomerular disease recurrence in the renal allograft: a hurdle but not a barrier for successful kidney transplantation","volume":"45","author":"Marinaki","year":"2013","journal-title":"Transpl Proc"},{"issue":"7","key":"10.1016\/j.transci.2023.103844_bib57","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1056\/NEJMoa1803537","article-title":"Plasma exchange and glucocorticoids in severe anca-associated vasculitis","volume":"382","author":"Walsh","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.transci.2023.103844_bib58","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1523-1755.2004.00428.x","article-title":"Retransplantation in alport post-transplant anti-GBM disease","volume":"65","author":"Browne","year":"2004","journal-title":"Kidney Int"},{"issue":"4","key":"10.1016\/j.transci.2023.103844_bib59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.kint.2021.05.015","article-title":"Executive summary of the KDIGO 2021 guideline for the management of glomerular diseases","volume":"100","author":"Rovin","year":"2021","journal-title":"Kidney Int"},{"issue":"1","key":"10.1016\/j.transci.2023.103844_bib60","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/annrheumdis-2020-218272","article-title":"Update on the diagnosis and management of systemic lupus erythematosus","volume":"80","author":"Fanouriakis","year":"2021","journal-title":"Ann Rheum Dis"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223002641?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050223002641?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:56:17Z","timestamp":1761468977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050223002641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1473050223002641"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2023.103844","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic apheresis in renal transplantation: An update","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2023.103844","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103844"}}